STAT+: Immunogen drug prolongs survival of women with advanced ovarian cancer
STAT
JUNE 4, 2023
CHICAGO — An antibody that delivers chemotherapy directly to tumor cells extended the lives of women with a form of advanced ovarian cancer in a large study, researchers reported Sunday. The drug, called Elahere, is made by the biotech company Immunogen. It was granted conditional approval in the U.S. last November based on preliminary evidence showing it shrank tumors.
Let's personalize your content